Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -15.69% is 24% below its 5-year average of -12.67%, around the middle of its 5-year range (-34.44%–5.11%).
As of the fiscal period ended Tuesday, June 30, 2026. 910.37% below its 12-month average of -1.55%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -15.69%.
RETURN ON INVESTED CAPITAL (ROIC)
-15.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-4.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-12.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-9.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-12.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-910.37%
CURRENT VS 3Y AVG
-253.49%
CURRENT VS 5Y AVG
-23.83%
CURRENT VS 10Y AVG
-69.64%
CURRENT VS 15Y AVG
-30.01%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+56.00%
vs the sector median at left
Aurora Cannabis Inc.
Market Cap
$284.31M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-1.55%
3Y Avg
-4.44%
5Y Avg
-12.67%
Market Cap
$285.55M
Return on Invested Capital (ROIC)
-49.76%
TTM Avg
-54.76%
3Y Avg
-73.23%
5Y Avg
-84.98%
Market Cap
$281.54M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
Market Cap
$282.64M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$285.42M
Return on Invested Capital (ROIC)
-20.40%
TTM Avg
-43.02%
3Y Avg
-57.92%
5Y Avg
-48.43%
Market Cap
$280.37M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$288.79M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-130.82%
3Y Avg
-85.38%
5Y Avg
-76.42%
Market Cap
$293.30M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
Market Cap
$292.59M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $284.31M | -15.69% | -1.55% | -4.44% | -12.67% |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | -49.76% | -54.76% | -73.23% | -84.98% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | -27.62% | -16.38% | -32.77% | -39.71% |
| Standard BioTools Inc. (LAB)vs › | $282.64M | -14.06% | -26.07% | -28.37% | -26.89% |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | -20.40% | -43.02% | -57.92% | -48.43% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | -61.10% | -38.45% | -31.16% | -81.63% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | -136.49% | -130.82% | -85.38% | -76.42% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | -129.90% | -509.42% | -303.54% | -247.13% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | -122.21% | -122.21% | -122.21% | -122.21% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -74.73% | -25.64% | -13.00% | -6.89% |
ROIC
-15.7%
ROE
-21.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -15.69% |
| 2026-03-31 | -0.17% |
| 2025-12-31 | -0.73% |
| 2025-09-30 | 3.71% |
| 2025-06-30 | 5.11% |
| 2025-03-31 | 0.49% |
| 2024-12-31 | 4.60% |
| 2024-09-30 | -2.16% |
| 2024-06-30 | -3.22% |
| 2024-03-31 | -5.21% |
| 2023-12-31 | -8.18% |
| 2023-09-30 | -15.48% |
| 2023-06-30 | -20.77% |
| 2023-03-31 | -25.00% |
| 2022-12-31 | -29.54% |
| 2022-09-30 | -25.54% |
| 2022-06-30 | -23.24% |
| 2022-03-31 | -29.40% |
| 2021-12-31 | -34.44% |
| 2021-09-30 | -30.98% |
| 2021-06-30 | -10.19% |
| 2021-03-31 | -15.01% |
| 2020-12-31 | -12.94% |
| 2020-09-30 | -16.79% |
| 2020-06-30 | -17.86% |
| 2020-03-31 | -7.67% |
| 2019-12-31 | -6.89% |
| 2019-09-30 | -5.12% |
| 2019-06-30 | -5.84% |
| 2019-03-31 | -5.88% |
| 2018-12-31 | -5.89% |
| 2018-09-30 | -3.93% |
| 2018-06-30 | -4.65% |
| 2018-03-31 | -3.24% |
| 2017-12-31 | -3.06% |
| 2017-09-30 | -2.76% |
| 2017-06-30 | -3.67% |
| 2017-03-31 | -5.19% |
| 2016-12-31 | -5.72% |
| 2016-09-30 | -4.40% |
| 2016-06-30 | -1.76% |
| 2016-03-31 | -0.01% |
| 2015-12-31 | -1.10% |
| 2015-09-30 | -4.22% |
| 2015-06-30 | -6.82% |
| 2015-03-31 | -11.09% |
| 2014-12-31 | -11.15% |
| 2014-09-30 | -7.93% |
| 2014-06-30 | -16.44% |
| 2014-03-31 | -49.28% |
| 2013-12-31 | -41.65% |
| 2013-09-30 | -45.25% |
| 2013-06-30 | -60.78% |
| 2013-03-31 | -63.34% |
| 2012-12-31 | -53.40% |
| 2012-09-30 | -45.82% |
| 2012-06-30 | -30.73% |
| 2012-03-31 | -14.70% |
| 2011-12-31 | -15.66% |
| 2011-09-30 | -16.49% |
| 2011-06-30 | -14.37% |
| 2011-03-31 | -13.05% |
| 2010-12-31 | -9.72% |
| 2010-09-30 | -7.63% |
| 2010-06-30 | -6.89% |
| 2010-03-31 | -3.08% |
| 2009-12-31 | -3.09% |
| 2009-09-30 | -4.36% |
| 2009-06-30 | -9.25% |
| 2009-03-31 | -14.05% |
| 2008-12-31 | -12.88% |
| 2008-09-30 | -19.80% |
| 2008-06-30 | -13.80% |
